An Open-label, Multi-center, Longitudinal, Within-subject Comparison Study to Evaluate the
Effects of Aripiprazole Once Monthly in Subjects with Schizophrenia on 30-, 90-, and 180- day
Re-hospitalization Rates Following Hospital Discharge Compared with Retrospective
Re-hospitalization Rates while on Oral Antipsychotic Medication.
Phase:
N/A
Details
Lead Sponsor:
Florida Atlantic University
Collaborators:
Burrell Behavioral Health University of Missouri-Columbia University of Missouri, Kansas City Washington University School of Medicine